FNNZF - FinCanna Capital Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

FinCanna Capital Corp.

800 West Pender Street
Suite 550
Vancouver, BC V6C 2V6

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Andriyko Taras Herchak B.Com., C.A., CPA, CACEO & DirectorN/AN/A1972
Mr. Robert James Scott C.A., C.F.A., CPA, CPA, CA, CFACFO & DirectorN/AN/AN/A
Mr. Jeffrey DareCorp. Sec. & DirectorN/AN/A1980
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


FinCanna Capital Corp. operates as a royalty investment company for the licensed medical cannabis industry in the United States. It provides financing for companies operating in the medical cannabis sector in exchange for a royalty on revenues. The company has royalty agreements with Cultivation Technologies Inc.; Green Compliance Inc.; QVI, Inc.; and Refined Resin Technologies Inc. FinCanna Capital Corp. is headquartered in Vancouver, Canada.

Corporate Governance

FinCanna Capital Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.